--Next-generation obesity company with potential best- and first-in-class assets launched by Versant Ventures-- --Emerges from stealth with $30 million in Series A financing and a strategic collaboration

Related Keywords

Canada , Steve Edelson , Sharon Barr , Alex Mayweg , Philip Larsen , Basel Technology Park , Astrazeneca , Versant Ventures , Ridgeline Discovery Engine , Managing Director , Versant Venture Ridgeline Discovery Engine , Basel Technology , Ihr Portfolio ,